Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb;49(2):172-9.
doi: 10.1097/MLR.0b013e3182028ff2.

The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation

William R Carpenter  1 , Katherine Reeder-Hayes, John Bainbridge, Anne-Marie Meyer, Keith D Amos, Bryan J Weiner, Paul A Godley
Affiliations

The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation

William R Carpenter et al. Med Care. 2011 Feb.

Abstract

Introduction: The National Institutes of Health (NIH) sees provider-based research networks and other organizational linkages between academic researchers and community practitioners as promising vehicles for accelerating the translation of research into practice. This study examines whether organizational research affiliations and teaching affiliations are associated with accelerated diffusion of sentinel lymph node biopsy (SLNB), an innovation in the treatment of early-stage breast cancer.

Methods: Surveillance Epidemiology and End Results-Medicare data were used to examine the diffusion of SLNB for treatment of early-stage breast cancer among women aged 65 years and older diagnosed between 2000 and 2002, shortly after Medicare approved and began reimbursing for the procedure.

Results: In this population, patients treated at an organization affiliated with a research network--the American College of Surgeons Oncology Group (ACOSOG) or other National Cancer Institute (NCI) cooperative groups--were more likely to receive the innovative treatment (SLNB) than patients treated at unaffiliated organizations (odds ratio: 2.70, 95% confidence interval: 1.77-4.12; odds ratio: 1.84, 95% confidence interval: 1.26-2.69, respectively). Neither hospital teaching status nor surgical volume was significantly associated with differences in SLNB use.

Discussion: Patients who receive cancer treatment at organizations affiliated with cancer research networks have an enhanced probability of receiving SLNB, an innovative procedure that offers the promise of improved patient outcomes. Study findings support the NIH Roadmap and programs such as the NCI's Community Clinical Oncology Program, as they seek to accelerate the translation of research into practice by simultaneously accelerating and broadening cancer research in the community.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Predicted probability of SLNB by Affiliation Status of Surgical Institution, 2000–2002. *Adjusted for race, age, marital status, grade, stage, estrogen receptor status, comorbidity index, census tract education, and income.
See this image and copyright information in PMC

References

    1. Balas E. Information technology and physician decision support. Program and abstracts of Accelerating Quality Improvement in Health Care: Strategies to Speed the Diffusion of Evidence-based Innovations, sponsored by National Committee for Quality Health Care; January 27–28, 2003; Washington, DC.
    1. Zerhouni E. The NIH Roadmap. Science. 2003;302:63–72. - PubMed
    1. Zerhouni E. Translational and clinical science—time for a new vision. N Engl J Med. 2005;353:1621–1623. - PubMed
    1. Lenfant C. Shattuck lecture—clinical research to clinical practice—lost in translation? N Engl J Med. 2003;349:868–874. - PubMed
    1. Lenfant C. Claude Lenfant, MD: retiring NHLBI director looks ahead. Interviewed by Brian Vastag. JAMA. 2003;290:1017–1018. - PubMed

Publication types

MeSH terms